Cancer Progress and Priorities: Gastric Cancer-Reply
Cancer Epidemiol Biomarkers Prev
.
2023 Sep 1;32(9):1271.
doi: 10.1158/1055-9965.EPI-23-0533.
Authors
Priya Alagesan
1
,
Jessica C Goodwin
2
3
,
Katherine S Garman
4
5
,
Meira Epplein
2
4
Affiliations
1
Duke University School of Medicine, Durham, North Carolina.
2
Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.
3
Morehouse School of Medicine, Atlanta, Georgia.
4
Cancer Risk, Detection, and Interception Program, Duke Cancer Institute, Durham, North Carolina.
5
Division of Gastroenterology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
PMID:
37655425
PMCID:
PMC10656104
DOI:
10.1158/1055-9965.EPI-23-0533
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Comment
Grants and funding
P20 CA251657/CA/NCI NIH HHS/United States
P30 CA014236/CA/NCI NIH HHS/United States
CA014236/CA/NCI NIH HHS/United States
CA251657/CA/NCI NIH HHS/United States